Forte Biosciences's EBIT per Share for the
three
months ended in Mar. 2024 was $-0.17.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $-1.01.
During the past 3 years, the average EBIT per Share Growth Rate was 19.00% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Forte Biosciences's EBIT per Share or its related term are showing as below:
FBRX'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 19 Med: 19 Max: 19
Current: 19
During the past 4 years, the highest 3-Year average EBIT per Share Growth Rate of Forte Biosciences was 19.00% per year. The lowest was 19.00% per year. And the median was 19.00% per year.
FBRX's 3-Year EBIT Growth Rate is ranked better than 69.66% of 1305
companies
in the Biotechnology industry
Industry Median: 3.6
vs FBRX: 19.00
The historical data trend for Forte Biosciences's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Forte Biosciences (NAS:FBRX) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Forte Biosciences EBIT per Share Related Terms
Thank you for viewing the detailed overview of Forte Biosciences's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Forte Biosciences (Forte Biosciences) Business Description
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease ("GvHD"), vitiligo and alopecia areata ("AA"). The company is developing a live biotherapeutic, FB-401, for the treatment of inflammatory skin diseases. FB-401 has completed Phase 1/2a testing in adult and pediatric patients with atopic dermatitis. It plans to advance FB-401 into a randomized Phase 2 clinical trial.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FBRX has been successfully added to your 